Fady Ibraham Malik Cytokinetics Inc (CYTK) insider trading activity

Fady Ibraham Malik is EVP Research & Development of CYTOKINETICS INC. Currently has a direct ownership of 140,610 shares of CYTK, which is worth approximately $4.82 Million. The most recent transaction as insider was on Aug 12, 2021, when has been sold 2,000 shares (Common Stock) at a price of $32.6 per share, resulting in proceeds of $65,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 141K

0.25% 3M change

10.71% 12M change

Total Value Held $4.82 Million

Fady Ibraham Malik Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 12 2021	SELL Open market or private sale	$65,200 $32.6 p/Share	2,000 Reduced 1.27%	154,878 Common Stock
Jul 08 2021	SELL Open market or private sale	$38,960 $19.48 p/Share	2,000 Reduced 1.26%	156,878 Common Stock
Jun 10 2021	SELL Open market or private sale	$42,960 $21.48 p/Share	2,000 Reduced 1.24%	158,878 Common Stock
May 13 2021	SELL Open market or private sale	$48,840 $24.42 p/Share	2,000 Reduced 1.23%	160,348 Common Stock
Apr 08 2021	SELL Open market or private sale	$46,780 $23.39 p/Share	2,000 Reduced 1.22%	162,348 Common Stock
Mar 11 2021	SELL Open market or private sale	$39,800 $19.9 p/Share	2,000 Reduced 1.2%	164,348 Common Stock
Mar 08 2021	SELL Payment of exercise price or tax liability	$146,496 $19.19 p/Share	7,634 Reduced 4.39%	166,348 Common Stock
Mar 02 2021	BUY Grant, award, or other acquisition	-	35,000 Added 16.75%	173,982 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$54,399 $19.66 p/Share	2,767 Reduced 1.95%	138,982 Common Stock
Feb 26 2021	SELL Payment of exercise price or tax liability	$132,234 $18.73 p/Share	7,060 Reduced 4.74%	141,749 Common Stock
Feb 11 2021	SELL Open market or private sale	$38,091 $23.34 p/Share	1,632 Reduced 1.08%	148,809 Common Stock
Jan 14 2021	SELL Open market or private sale	$240,625 $19.25 p/Share	12,500 Reduced 7.67%	150,441 Common Stock
Jan 14 2021	BUY Exercise of conversion of derivative security	$117,750 $9.42 p/Share	12,500 Added 7.15%	162,324 Common Stock
Dec 10 2020	SELL Open market or private sale	$21,177 $20.13 p/Share	1,052 Reduced 0.69%	150,441 Common Stock
Nov 12 2020	SELL Open market or private sale	$21,112 $17.15 p/Share	1,231 Reduced 0.81%	150,951 Common Stock
Oct 08 2020	SELL Open market or private sale	$21,952 $17.45 p/Share	1,258 Reduced 0.82%	152,182 Common Stock

Also insider at

RCKT

ROCKET PHARMACEUTICALS, INC. Healthcare

FIM